Marc and Jennifer Lipschultz Precision Immunology Institute
The immune system has a role in almost every disease, from infections and cancers to Alzheimer’s, and is even crucial for normal childhood development. Drugs that modulate the immune system are revolutionizing the treatment of numerous diseases, including arthritis, inflammatory bowel disease, and cancer. The scope of this emerging medical revolution requires a new commitment to basic and clinical immunology research that will lead to new immune diagnostics and therapeutics, and uncover the genetic and environmental triggers of immune and inflammatory diseases. To meet these goals, the Icahn School of Medicine at Mount Sinai has established the Precision Immunology Institute at the Icahn School of Medicine (PrIISM), a new entity that encompasses and integrates disease-focused immunological research programs and cutting-edge technology centers.